21 Cathie Wood Ionis Pharmaceuticals Trades
Cathie Wood acquired 4.7 Million Ionis Pharmaceuticals shares worth $215 Million. That's 1.16% of their equity portfolio (24th largest holding). The investor owns 3.50% of the outstanding Ionis Pharmaceuticals stock. The first Ionis Pharmaceuticals trade was made in Q4 2016. Since then Cathie Wood bought shares twelve more times and sold shares on eight occasions. The investor's estimated purchase price is $223 Million, resulting in a loss of 3.8%.
Avg closing price
Price range
Sold 23.8% shares (-1.47 Million shares)
Q2 2022
Avg closing price
$37.71
Price range
$31.71
-
$43.00
Sold 12.9% shares (-912 Thousand shares)
Q1 2022
Avg closing price
$32.73
Price range
$29.88
-
$37.04
Sold 16.8% shares (-1.43 Million shares)
Q4 2021
Avg closing price
$31.48
Price range
$25.61
-
$35.10
Sold 4.4% shares (-396 Thousand shares)
Q3 2021
Avg closing price
$37.68
Price range
$33.54
-
$40.55
Increased shares by 73.2% (+3.77 Million shares)
Q2 2021
Avg closing price
$39.17
Price range
$34.54
-
$47.25
Increased shares by 114.3% (+2.74 Million shares)
Q1 2021
Avg closing price
$55.77
Price range
$42.51
-
$63.78
Increased shares by 377.5% (+1.9 Million shares)
Q4 2020
Avg closing price
$49.83
Price range
$45.30
-
$60.27
Increased shares by 46.0% (+158 Thousand shares)
Q3 2020
Avg closing price
$55.55
Price range
$47.45
-
$62.95
Increased shares by 187.5% (+224 Thousand shares)
Q2 2020
Avg closing price
$55.63
Price range
$46.85
-
$61.05
Sold 44.6% shares (-96.3 Thousand shares)
Q1 2020
Avg closing price
$55.74
Price range
$41.60
-
$63.40
Increased shares by 30.9% (+51 Thousand shares)
Q4 2019
Avg closing price
$59.58
Price range
$53.85
-
$65.27
Sold 31.9% shares (-77.3 Thousand shares)
Q1 2019
Avg closing price
$64.51
Price range
$52.92
-
$81.17
Increased shares by 5.7% (+13 Thousand shares)
Q4 2018
Avg closing price
$51.00
Price range
$43.37
-
$59.54
Increased shares by 7.6% (+16.2 Thousand shares)
Q3 2018
Avg closing price
$46.98
Price range
$42.88
-
$53.70
Sold 39.4% shares (-139 Thousand shares)
Q2 2018
Avg closing price
$44.33
Price range
$40.52
-
$50.70
Sold 5.1% shares (-18.9 Thousand shares)
Q1 2018
Avg closing price
$50.80
Price range
$44.08
-
$55.05
Increased shares by 49.9% (+123 Thousand shares)
Q4 2017
Avg closing price
$54.84
Price range
$50.30
-
$64.39
Increased shares by 39.8% (+70.5 Thousand shares)
Q3 2017
Avg closing price
$52.38
Price range
$45.56
-
$59.57
Increased shares by 38.7% (+49.4 Thousand shares)
Q2 2017
Avg closing price
$46.57
Price range
$37.91
-
$55.50
Increased shares by 1826.6% (+121 Thousand shares)
Q1 2017
Avg closing price
$44.91
Price range
$37.93
-
$54.70
